Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design
The computational identification of peptides that can bind the major histocompatibility complex (MHC) with high affinity is an essential step in developing personal immunotherapies and vaccines. We introduce PUFFIN, a deep residual network-based computational approach that quantifies uncertainty in...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/128919 |
_version_ | 1811083222561325056 |
---|---|
author | Zeng, Haoyang Gifford, David K |
author2 | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory |
author_facet | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Zeng, Haoyang Gifford, David K |
author_sort | Zeng, Haoyang |
collection | MIT |
description | The computational identification of peptides that can bind the major histocompatibility complex (MHC) with high affinity is an essential step in developing personal immunotherapies and vaccines. We introduce PUFFIN, a deep residual network-based computational approach that quantifies uncertainty in peptide-MHC affinity prediction that arises from observational noise and the lack of relevant training examples. With PUFFIN's uncertainty metrics, we define binding likelihood, the probability a peptide binds to a given MHC allele at a specified affinity threshold. Compared to affinity point estimates, we find that binding likelihood correlates better with the observed affinity and reduces false positives in high-affinity peptide design. When applied to examine an existing peptide vaccine, PUFFIN identifies an alternative vaccine formulation with higher binding likelihood. PUFFIN is freely available for download at http://github.com/gifford-lab/PUFFIN. Machine-learning models that predict the binding affinity of a peptide-MHC pair are essential in peptide-based therapeutic design, but state-of-the-art methods provide point estimates of affinity that do not consider measurement noise and model uncertainty. We introduce PUFFIN, a method that quantifies the prediction uncertainty and prioritizes peptides with “binding likelihood” to achieve improved accuracy in high-affinity peptide selection for therapeutic design. |
first_indexed | 2024-09-23T12:28:55Z |
format | Article |
id | mit-1721.1/128919 |
institution | Massachusetts Institute of Technology |
language | English |
last_indexed | 2024-09-23T12:28:55Z |
publishDate | 2020 |
publisher | Elsevier BV |
record_format | dspace |
spelling | mit-1721.1/1289192022-09-28T08:07:37Z Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design Zeng, Haoyang Gifford, David K Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science The computational identification of peptides that can bind the major histocompatibility complex (MHC) with high affinity is an essential step in developing personal immunotherapies and vaccines. We introduce PUFFIN, a deep residual network-based computational approach that quantifies uncertainty in peptide-MHC affinity prediction that arises from observational noise and the lack of relevant training examples. With PUFFIN's uncertainty metrics, we define binding likelihood, the probability a peptide binds to a given MHC allele at a specified affinity threshold. Compared to affinity point estimates, we find that binding likelihood correlates better with the observed affinity and reduces false positives in high-affinity peptide design. When applied to examine an existing peptide vaccine, PUFFIN identifies an alternative vaccine formulation with higher binding likelihood. PUFFIN is freely available for download at http://github.com/gifford-lab/PUFFIN. Machine-learning models that predict the binding affinity of a peptide-MHC pair are essential in peptide-based therapeutic design, but state-of-the-art methods provide point estimates of affinity that do not consider measurement noise and model uncertainty. We introduce PUFFIN, a method that quantifies the prediction uncertainty and prioritizes peptides with “binding likelihood” to achieve improved accuracy in high-affinity peptide selection for therapeutic design. National Institute of Health (Grant R01CA218094) 2020-12-23T20:34:01Z 2020-12-23T20:34:01Z 2019-08 2019-03 2020-12-15T17:09:55Z Article http://purl.org/eprint/type/JournalArticle 2405-4712 https://hdl.handle.net/1721.1/128919 Zeng, Haoyang and David K. Gifford. "Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design." Cell Systems 9, 2 (August 2019): P159-166.e3 © 2019 Elsevier Inc en http://dx.doi.org/10.1016/j.cels.2019.05.004 Cell Systems Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier BV PMC |
spellingShingle | Zeng, Haoyang Gifford, David K Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title | Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title_full | Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title_fullStr | Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title_full_unstemmed | Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title_short | Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design |
title_sort | quantification of uncertainty in peptide mhc binding prediction improves high affinity peptide selection for therapeutic design |
url | https://hdl.handle.net/1721.1/128919 |
work_keys_str_mv | AT zenghaoyang quantificationofuncertaintyinpeptidemhcbindingpredictionimproveshighaffinitypeptideselectionfortherapeuticdesign AT gifforddavidk quantificationofuncertaintyinpeptidemhcbindingpredictionimproveshighaffinitypeptideselectionfortherapeuticdesign |